ReproNovo

Lausanne, Switzerland

ReproNovo specializes in reproductive health and women's health.

$65.0M raised

May 2025

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has ReproNovo raised?

ReproNovo has raised $65.0M in total funding. The most recent round was Series A. The last funding was announced in May 2025.

Who are ReproNovo's investors?

ReproNovo's investors include Jeito Capital, Ysios Capital, M Ventures, ALSA Ventures, AXA Alternative Investments.

Where is ReproNovo headquartered?

ReproNovo is headquartered in Lausanne, Switzerland.

What does ReproNovo do?

ReproNovo specializes in reproductive health and women's health.

What stage is ReproNovo at?

ReproNovo is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 21, 2025.

MLA

"ReproNovo — Funding & Investors." VCBacked, May 21, 2025, https://www.vcbacked.co/company/repronovo. Accessed July 3, 2026.

APA

VCBacked. (2025). ReproNovo — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/repronovo

Wikipedia (cite web)

{{cite web |title=ReproNovo — Funding & Investors |url=https://www.vcbacked.co/company/repronovo |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 21, 2025.